5PSQ-075 Fingolimod-associated lymphopaenia in multiple sclerosis patients

BACKGROUND: Fingolimod changes lymphocyte count. PURPOSE: To evaluate changes in lymphocyte count and infection incidence in patients with multiple sclerosis (MS) receiving fingolimod. MATERIAL AND METHODS: Retrospective study that included all fingolimod-treated patients in a tertiary hospital. Pat...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Eur J Hosp Pharm
Huvudupphovsmän: Navarro, M, Betancor, T, Diaz, P, Calzado, G, Ramos, E, Suárez, M, Vera, M, Plasencia, I, Ferrer, A, Merino, J
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Group 2018
Ämnen:
Section 5: Patient safety and quality assurance
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535408/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.429
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk